3D cell culture is a highly effective method to collect breast cancer stem cells in vitro
Abstract
Introduction: Breast cancer continues to be one of the most common malignancies in females, with mortality rates among the highest worldwide. Despite the availability of numerous clinical tools for managing breast cancer, recurrence, metastasis, and drug resistance remain significant barriers for clinical experts. Scientists consider these tumorigenic processes to be closely associated with breast cancer stem cells (BCSCs). While extensive research focuses on breast cancer cell lines in vitro, replicating the intricate dynamics of the internal tumor microenvironment remains a challenge. This microenvironment is influenced not only by biochemical factors but also by biomechanical cues, such as ECM stiffness and shear stress, which regulate cancer cell behavior through mechanotransduction pathways. Recognizing these limitations, our team has drawn upon years of cancer stem cell research to establish a practicable method. This method aims to facilitate a series of experiments exploring drug resistance mechanisms and to provide deeper insights into the role of BCSCs in tumorigenesis and progression in vivo. Materials and methods: 3-dimensional (3D) mammosphere culture method was established to enrich the breast cancer stem-like cells in vitro. Mammospheres forming assay was performed and mammosphere forming efficiency was calculated. Flow cytometry Analysis was used to detect the subpopulation of CD44+CD24−, meanwhile, the biomarkers of BCSCs were detected by western blot. All these indicates the success establishment of 3D cell culture method and the breast cancer stem-like cells are enriched and collected. Furtherly, western blots were performed to detect the conjectures of the BCSCs that the Notch signaling pathway and MAPK-ERK signaling have the crosstalk in breast cancer microenvironment and the positive feedback loops could be activated by the enriching of BCSCs. All these data were analyzed with GraphPad® Prism 9 software and Wilcoxon rank-sum test, nonlinear regression analysis, unpaired t tests were used. Results: MCF-7 breast cancer stem-like cells were observed as substantially distinct from native breast cell lines under 20x microscope and the mammosphere forming efficiency of MCF-7 breast cancer stem-like cells were higher than the native MCF-7 group. The subpopulation of CD44+CD24− was significantly increased in BCSC-like group and the EMT (Epithelial-Mesenchymal Transition) markers of BCSC which includes Nanog; Vimentin; OCT3/4; Slug and Sox2 were significantly increased. Lastly, Cyclin D3 and Hes1 which play important roles in the Notch signaling pathway and ERK protein were all significantly increased. Conclusion: The three-dimensional (3D) mammosphere culture method is a highly effective approach for collecting breast cancer stem cells (BCSCs) in vitro. Unlike traditional 2D cultures, this method replicates key physiological conditions of the tumor microenvironment (TME) and captures phenotypic heterogeneity. By promoting cell-cell and cell-ECM interactions, the 3D system mimics essential biomechanical cues, such as ECM stiffness and spatial gradients, which regulate BCSC behavior. This method reliably supports investigations into the molecular mechanisms of tumorigenesis. BCSCs enriched through this approach drive processes such as epithelial-mesenchymal transition (EMT) and activate signaling pathways like Notch and MAPK-ERK, which are closely linked to the TME and play critical roles in tumor progression and resistance. The 3D mammosphere culture method thus provides a robust tool for advancing our understanding of cancer biology and therapeutic development.
References
1. Sung, H., et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021. 71(3): p. 209-249.
2. Wilkinson, L. and T. Gathani, Understanding breast cancer as a global health concern. Br J Radiol, 2022. 95(1130): p. 20211033.
3. Najafi, M., K. Mortezaee, and J. Majidpoor, Cancer stem cell (CSC) resistance drivers. Life Sci, 2019. 234: p. 116781.
4. Ayob, A.Z. and T.S. Ramasamy, Cancer stem cells as key drivers of tumour progression. Journal of Biomedical Science, 2018. 25(1): p. 20.
5. Luo, M., et al., Breast cancer stem cells: current advances and clinical implications. Methods Mol Biol, 2015. 1293: p. 1-49.
6. Velasco-Velázquez, M.A., et al., Targeting Breast Cancer Stem Cells: A Methodological Perspective. Curr Stem Cell Res Ther, 2019. 14(5): p. 389-397.
7. Li, Y., et al., Drug resistance and Cancer stem cells. Cell Commun Signal, 2021. 19(1): p. 19.
8. Sher G, Masoodi T, Patil K, et al. Dysregulated FOXM1 signaling in the regulation of cancer stem cells.Seminars in cancer biology. Academic Press, 2022, 86: 107-121.
9. Chimento, A., et al., Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance. Int J Mol Sci, 2022. 23(11).
10. Kumar, P., et al., tRFdb: a database for transfer RNA fragments. Nucleic Acids Res, 2015. 43(Database issue): p. D141-5.
11. Qin, M.Y., et al., Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway. J Ethnopharmacol, 2021. 280: p. 114414.
12. Wang, Q., et al., Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyond. Front Genet, 2024. 15: p. 1346852.
13. Pampaloni, F., E.G. Reynaud, and E.H. Stelzer, The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol, 2007. 8(10): p. 839-45.
14. Cukierman, E., et al., Taking cell-matrix adhesions to the third dimension. Science, 2001. 294(5547): p. 1708-12.
15. Weiswald, L.B., D. Bellet, and V. Dangles-Marie, Spherical cancer models in tumor biology. Neoplasia, 2015. 17(1): p. 1-15.
16. Mseka, T., J.R. Bamburg, and L.P. Cramer, ADF/cofilin family proteins control formation of oriented actin-filament bundles in the cell body to trigger fibroblast polarization. J Cell Sci, 2007. 120(Pt 24): p. 4332-44.
17. Baal, N., et al., In vitro spheroid model of placental vasculogenesis: does it work? Lab Invest, 2009. 89(2): p. 152-63.
18. Friedrich, J., et al., Spheroid-based drug screen: considerations and practical approach. Nat Protoc, 2009. 4(3): p. 309-24.
19. Baker, B.M. and C.S. Chen, Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci, 2012. 125(Pt 13): p. 3015-24.
20. Mehta, G., et al., Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release, 2012. 164(2): p. 192-204.
21. Nath, S. and G.R. Devi, Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther, 2016. 163: p. 94-108.
22. Lee, S.Y., et al., In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models. SLAS Discov, 2023. 28(4): p. 119-137.
23. Lombardo, Y., et al., Mammosphere formation assay from human breast cancer tissues and cell lines. J Vis Exp, 2015(97).
24. Marbury, T., et al., Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study. J Cancer, 2023. 14(9): p. 1571-1578.
25. Naor, D., et al., CD44 in cancer. Crit Rev Clin Lab Sci, 2002. 39(6): p. 527-79.
26. Gao, R., et al., CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism. Theranostics, 2018. 8(22): p. 6248-6262.
27. Habanjar, O., et al., 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages. Int J Mol Sci, 2021. 22(22).
28. Idrisova, K.F., H.U. Simon, and M.O. Gomzikova, Role of Patient-Derived Models of Cancer in Translational Oncology. Cancers (Basel), 2022. 15(1).
29. Kashyap, V., et al., Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev, 2009. 18(7): p. 1093-108.
30. Mossahebi-Mohammadi, M., et al., FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency. Front Cell Dev Biol, 2020. 8: p. 79.
31. Wang, Z.X., et al., Oct4 and Sox2 directly regulate expression of another pluripotency transcription factor, Zfp206, in embryonic stem cells. J Biol Chem, 2007. 282(17): p. 12822-30.
32. Rodda, D.J., et al., Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem, 2005. 280(26): p. 24731-7.
33. Boyer, L.A., et al., Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 2005. 122(6): p. 947-56.
34. Chan, Y.S., L. Yang, and H.H. Ng, Transcriptional regulatory networks in embryonic stem cells. Prog Drug Res, 2011. 67: p. 239-52.
35. Savagner, P., The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol, 2010. 21 Suppl 7: p. vii89-92.
36. Lo, U.G., et al., The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression. Int J Mol Sci, 2017. 18(10).
37. Vuoriluoto, K., et al., Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene, 2011. 30(12): p. 1436-48.
38. Winter, M., et al., Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment. Cells, 2021. 10(6).
39. Guo, S., M. Liu, and R.R. Gonzalez-Perez, Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta, 2011. 1815(2): p. 197-213.
40. Sun, Y., et al., Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res, 2015. 35(6): p. 600-4.
41. Nikhil, K., et al., Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status. PLoS One, 2014. 9(4): p. e93335.
42. Zhan, Y.H., et al., β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways. Asian Pac J Cancer Prev, 2012. 13(6): p. 2739-44.
Copyright (c) 2025 Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.